Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes
about
Establishment of a risk scoring system for predicting locoregional recurrence in T1 to T2 node-negative breast cancer patients treated with mastectomy: Implications for postoperative radiotherapy.Predictors of recurrence in breast cancer subtypes with negative lymph node in a Chinese population.Risk factors for distant metastasis as a primary site of treatment failure in early-stage breast cancer.Chemotherapy use and surgical treatment by receptor subtype in node-negative T1a and T1b female breast cancers, Iowa SEER Registry, 2010 to 2012.For or against adjuvant trastuzumab for pT1a-bN0M0 breast cancer patients with HER2-positive tumors: a meta-analysis of published literatures.The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial.Update on triple-negative breast cancer: prognosis and management strategiesRecurrence risk in small, node-negative, early breast cancer: a multicenter retrospective analysisFeatures of triple-negative breast cancer: Analysis of 38,813 cases from the national cancer databaseOutcomes of her2-positive early-stage breast cancer in the trastuzumab era: a population-based study of Canadian patients.Role of HER2-neu as a prognostic factor for survival and relapse in pT1a-bN0M0 breast cancer: a systematic review of the literature with a pooled-analysis.Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement.The 2014 Society of Surgical Oncology Susan G. Komen for the Cure Symposium: triple-negative breast cancer.Oncological safety and cosmetic outcomes in oncoplastic breast conservation surgery, a review of the best level of evidence literatureBenefit of adjuvant radiotherapy after breast-conserving therapy among elderly women with T1-T2N0 estrogen receptor-negative breast cancer.Rethinking the Local Therapy of Breast Cancer: Integration of Biology and Anatomy.Cavity Shaving Reduces Involved Margins and Reinterventions Without Increasing Costs in Breast-Conserving Surgery: A Propensity Score-Matched Study.Trends and controversies in multidisciplinary care of the patient with breast cancer.Impact of age, intrinsic subtype and local treatment on long-term local-regional recurrence and breast cancer mortality among low-risk breast cancer patients.Locoregional Control According to Breast Cancer Subtype and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Undergoing Breast-conserving Therapy.Evaluation of Local and Distant Recurrence Patterns in Patients with Triple-Negative Breast Cancer According to Age.Outcome of pN0 Triple-Negative Breast Cancer with or without Lymph Node Irradiation: A Single Institution Experience.Do T1a breast cancers profit from adjuvant systemic therapy? A multicenter retrospective cohort study of 325 T1a-patients.Postmastectomy radiotherapy benefit in Chinese breast cancer patients with T1-T2 tumor and 1-3 positive axillary lymph nodes by molecular subtypes: an analysis of 1369 cases.Risk of mortality of node-negative, ER/PR/HER2 breast cancer subtypes in T1, T2, and T3 tumors.Luminal-like HER2-negative stage IA breast cancer: a multicenter retrospective study on long-term outcome with propensity score analysis.Margins in breast cancer: How much is enough?Analysis in early stage triple-negative breast cancer treated with mastectomy without adjuvant radiotherapy: patterns of failure and prognostic factors.Prognostic role of elevated mir-24-3p in breast cancer and its association with the metastatic process.Glioma FMISO PET/MR Imaging Concurrent with Antiangiogenic Therapy: Molecular Imaging as a Clinical Tool in the Burgeoning Era of Personalized Medicine.Margins in DCIS: Does Residual Disease Provide an Answer?Effects of adjuvant chemotherapy in HER2-positive or triple-negative pT1ab breast cancers: a multi-institutional retrospective study.The effect of adjuvant chemotherapy on survival in Korean patients with node negative T1c, triple negative breast cancer.Favorable prognosis in patients with T1a/T1bN0 triple-negative breast cancers treated with multimodality therapy
P2860
Q33879820-45443702-11CF-46DB-ADCF-6906B0E266C6Q33898517-5CB51F07-CBF4-420E-B2CC-E3320ADB738FQ34774308-A0A86D7F-F9D8-4B49-8DE9-E9BBD34F429DQ34899436-9AD8ECA4-DA73-45AE-A3E7-21390C2A24B7Q35083252-D44806B8-07DA-454C-BF32-DE847B5B94FAQ35475576-5E59D444-9528-44F7-9C96-6EEA2D2B7937Q36311616-91144F81-218D-4212-9722-8C9858A34696Q36762888-B3E2CD5D-47A5-4898-995F-7A7988D10E59Q37226242-1F3E22A8-E10D-41A1-8192-6096B46D9BC9Q37364604-905B0F85-0B7B-4F0A-B019-D170E75DDF9AQ37993442-8F57800F-7789-483A-BCF1-7EC3EB518AE8Q38061108-1F2CC7E4-2ECC-4F0A-9EB3-E84B9C133337Q38295108-0497F6B7-F13B-4685-9E65-42C348EA46F0Q38613228-22882CC4-BE8F-4263-8A6D-167C1F3C39E1Q38850226-AE9E0599-ED93-48CA-ACCF-958CEE8F86B2Q38980661-9D56B052-7FFB-4D89-B281-0F47FA702F9FQ39100181-231CA610-C8DC-47FA-BEEB-1B111F13676AQ39119467-8915803F-5A55-40D1-9F6F-DCCB5F9F8335Q39185869-7F337519-E7B6-45B7-B518-6D5FA3CA478DQ40382522-7E06277D-4F9B-4916-B3B1-90702D49ED77Q40514586-1EB24407-1EE9-4101-BE58-5785F5F46595Q40719325-358D3ADB-E189-47F8-A273-AA2CEA5C4B2EQ40900023-AB894E1A-DFF7-45A8-B937-52DF474548D5Q41078060-5FE9F99F-52FE-4CB5-ACBC-9AF20351BDD7Q46841562-5DC4A75B-950D-4659-9AEE-47EB6BF372B1Q49948404-5E2BFC95-B0A1-4105-9303-9C64DFDCC268Q50026264-24763EF7-326A-4AAA-B029-4C5944358B39Q51075321-46D8BA2C-5090-46F1-A11C-8D912D824534Q52645858-E7F2B8C9-19DD-46B4-8493-D121E3255F44Q53109990-71B82DAA-54AD-4D16-91E4-7FEFCD6E64D8Q54295810-01A2055D-8DF3-47FD-811B-415E10D2B64DQ54453782-FB5237FA-997A-45AF-B0F3-6779508C93F0Q55094642-D1305E55-10CF-4187-B4EF-4FAD1D901F3FQ56928413-96BA7ADE-DFD7-4859-8DF3-32E3578A2C05
P2860
Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes
description
im März 2011 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 31 March 2011
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2011
@uk
name
Prognosis in women with small ...... tochemically selected subtypes
@en
Prognosis in women with small ...... tochemically selected subtypes
@nl
type
label
Prognosis in women with small ...... tochemically selected subtypes
@en
Prognosis in women with small ...... tochemically selected subtypes
@nl
prefLabel
Prognosis in women with small ...... tochemically selected subtypes
@en
Prognosis in women with small ...... tochemically selected subtypes
@nl
P2093
P2860
P50
P1476
Prognosis in women with small ...... tochemically selected subtypes
@en
P2093
A Cardillo
A Goldhirsch
E Montagna
G Cancello
P2860
P2888
P304
P356
10.1007/S10549-011-1465-7
P407
P577
2011-03-31T00:00:00Z